Pharma Market Access Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate.
Views & Analysis Specialty pharma’s next big opportunity: it’s time for patie... In January 2020, the financial conglomerate Visa
Market Access How the US’s pending PIE Act will improve patient access to ... Jennifer Mathieu, vice president of policy and government relations at the Academy of Managed Care Pharmacy (AMCP), tells us why the organisation backed the pre-approval information exchang
Partner Content Partner Content Patient and market insights from leading KOLs and life scien... Insights from leading KOLs in new Dermatology eBook
Partner Content Partner Content How digital connectivity is driving faster patient access Sotiria Papanicolaou's take on digital innovation
Sales & Marketing Sustained healthcare systems need sustainable pharma busines... COVID-19 demonstrated the importance of robust supply chains and the dangers of an over reliance on overseas manufacturing.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
